ACADIA Pharmaceuticals Inc. earnings per share and revenue

ACAD earnings per share for the last quarter are 0.28 USD whereas the estimation was 0.29 USD which accounts for -3.09% surprise. Company revenue for the same period amounts to 231.04 M USD despite the estimated figure of 223.79 M USD. Estimated earnings per share for the next quarter are 0.05 USD, and revenue is expected to reach 208.39 M USD. Also watch annual changes over time to get a bigger picture of ACAD earnings per share and revenue dynamics.